📢 Nous ouvrons notre capital pour libérer les patients de la douleur chronique 📢

Pour devenir actionnaire,  c’est par ici !

Remedee Labs solution is clinically validated for Osteoarthritis and Fibromyalgia

Following years of intensive research and development, Remedee Labs has developed a breakthrough approach to pain relief, by stimulating a person’s own endorphins.

In light of significant interest from the medical community to find new ways to relieve pain safely and effectively, the Remedee Labs endorphin-stimulation solution is being tested in multiple clinical trials.

A clinical study on Fibromyalgia | FIBREPIK

This clinical trial included 170 patients suffering from fibromyalgia in over 8 centers in France. The study lasted 6 months, with the aim of assessing the improvement in quality of life (FIQ) in fibromyalgia patients following the use of the Remedee solution (Wristband + human coaching).

The results were presented on Monday, November 13 by pain specialist Dr. Caroline Maindet at the annual meeting of the American College of Rheumatology (ACR) in San Diego (USA).

The study showed a clear improvement in patients’ quality of life as well as a significant decrease in pain, generalized and physical fatigue, anxiety, and depression, and an improvement in sleep quality.

A clinical study on osteoarthritis | EPIKARTHROSE

Remedee Labs’ innovative, non-invasive technology has been clinically tested on 60 volunteers with peripheral osteoarthritis (ankle, knee, hip, shoulder, elbow, digital) by the Grenoble-Alpes University Hospital.

The results of the study showed that regular use (1 to 3 times a day) of the endorphin stimulator for 3 months resulted in a significant reduction in pain (VAS) in osteoarthritis patients.

The authors of the study also noted an overall improvement in the quality of life (EQ5D-5L) and sleep quality (VAS) of the patients included. No adverse events considered severe were observed.